Antioxidant activities of novel resveratrol analogs in breast cancer
- 28 September 2017
- journal article
- research article
- Published by Wiley in Journal of Biochemical and Molecular Toxicology
- Vol. 32 (1)
Abstract
The objective of the present study was to characterize the role of novel resveratrol (Res) analogs: 4‐(E)‐{(4‐hydroxyphenylimino)‐methylbenzene, 1, 2‐diol} (HPIMBD) and 4‐(E)‐{(p‐tolylimino)‐methylbenzene‐1,2‐diol} (TIMBD) as potent antioxidants against breast cancer. Non‐neoplastic breast epithelial cell lines MCF‐10A and MCF‐10F were treated with 17β‐estradiol (E2), Res, HPIMBD, and TIMBD for up to 72 h. mRNA and protein levels of antioxidant genes, superoxide dismutase 3 (SOD3) and N‐quinoneoxidoreductase‐1 (NQO1) and transcription factors, nuclear factor erythroid 2‐related factor (Nrf) 1, 2 and 3 were quantified after the above treatments. Generation of reactive oxygen species (ROS) was measured by CM‐H2‐DCFDA and oxidative‐DNA damage was determined by measuring 8‐hydroxy‐2‐deoxyguanosine (8‐OHdG). HPIMBD and TIMBD scavenged cellular ROS production, attenuated oxidative DNA damage, increased mRNA and protein expression levels of SOD3 and NQO1 and activated Nrf signaling pathway. Our studies demonstrate that HPIMBD and TIMBD have the potential as novel antioxidants to prevent development of breast cancer.Keywords
Funding Information
- School of Pharmacy, University of Missouri-Kansas City
This publication has 44 references indexed in Scilit:
- Antioxidant-mediated up-regulation of OGG1 via NRF2 induction is associated with inhibition of oxidative DNA damage in estrogen-induced breast cancerBMC Cancer, 2013
- Stress-induced NQO1 controls stability of C/EBPα against 20S proteasomal degradation to regulate p63 expression with implications in protection against chemical-induced skin cancerOncogene, 2012
- Induction of NAD(P)H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancerCarcinogenesis, 2011
- Hereditary breast cancer: clinical features and risk reduction strategiesAnnals of Oncology, 2011
- Role of Nrf1 in antioxidant response element-mediated gene expression and beyondToxicology and Applied Pharmacology, 2010
- Stress-Activated Cap'n'collar Transcription Factors in Aging and Human DiseaseScience Signaling, 2010
- Nrf2:INrf2 (Keap1) signaling in oxidative stressFree Radical Biology and Medicine, 2009
- Vitamin C and -naphthoflavone prevent estrogen-induced mammary tumors and decrease oxidative stress in female ACI ratsCarcinogenesis, 2009
- Estrogen-induced breast cancer: Alterations in breast morphology and oxidative stress as a function of estrogen exposureToxicology and Applied Pharmacology, 2008
- Estrogen Carcinogenesis in Breast CancerNew England Journal of Medicine, 2006